SHIFT Newsroom · GLOBAL
Orforglipron after GLP-1 discontinuation: an editorial question
The cited item in Expert Review of Clinical Pharmacology is an editorial, not a new clinical trial.
The cited item in Expert Review of Clinical Pharmacology is an editorial, not a new clinical trial. Its title asks whether oral orforglipron can maintain weight loss after GLP-1 treatment stops. The bibliographic record reviewed here has no abstract, so it does not support reporting a trial result or a switching recommendation.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.